Prime-boost vectored malaria vaccines: Progress and prospects

This publication has 37 references indexed in Scilit:

• Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8 ⁺ T-Cell Responses
  Infection and Immunity, 2010
• Plasmodium falciparum-Specific Cellular Immune Responses after Immunization with the RTS,S/AS02D Candidate Malaria Vaccine in Infants Living in an Area of High Endemicity in Mozambique
  Infection and Immunity, 2009
• Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection
  The Journal of Infectious Diseases, 2009
• Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans
  Nature Medicine, 2009
• Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells
  Nature Medicine, 2009
• Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1 Induce Antibody- and T Cell-Mediated Multistage Protection against Malaria
  Cell Host & Microbe, 2009
• Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
  New England Journal of Medicine, 2008
• The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria
  Infection and Immunity, 2008
• Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge
  Infection and Immunity, 2007
• A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge
  Infection and Immunity, 2006